Brief: Pacira Biosciences Reports First Quarter 2023 Financial Results
May 3 (Reuters) - Pacira Biosciences Inc PCRX.O :
* PACIRA BIOSCIENCES REPORTS FIRST QUARTER 2023 FINANCIAL
RESULTS
* QTRLY NET LOSS OF $0.43 PER SHARE
* Q1 EARNINGS PER SHARE VIEW $0.62, REVENUE VIEW $158.8
MILLION --
REFINITIV IBES DATA
* REITERATED ITS FULL-YEAR 2023 FINANCIAL GUIDANCE
Source text for Eikon: ID:nGNX1rTtKM
Further company coverage: PCRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pacira Biosciences
See all newsBrief: Pacira Biosciences Inc - Proxy Advisory Firm Glass Lewis Recommends Stockholders Vote "For" All Of Pacira's Director Nominees
Brief: Pacira Biosciences Urges Stockholders To Vote "For" Election Of Pacira's Nominees On Blue Proxy Card
Brief: Doma Perpetual Urges Pacira Biosciences Shareholders To Judge Sale Price Adequacy
Brief: Doma Perpetual Capital Management Calls For Removal Of Pacira CEO And Strategic Sale
Brief: Pacira Biosciences Sends Letter To Stockholders Reiterating Superior Qualifications Of Its Board Nominees